DE602004032570D1 - Verfahren zur bestimmung der lebensfähigkeit von zellen - Google Patents

Verfahren zur bestimmung der lebensfähigkeit von zellen

Info

Publication number
DE602004032570D1
DE602004032570D1 DE602004032570T DE602004032570T DE602004032570D1 DE 602004032570 D1 DE602004032570 D1 DE 602004032570D1 DE 602004032570 T DE602004032570 T DE 602004032570T DE 602004032570 T DE602004032570 T DE 602004032570T DE 602004032570 D1 DE602004032570 D1 DE 602004032570D1
Authority
DE
Germany
Prior art keywords
cells
vitability
determining
viability
integrity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004032570T
Other languages
English (en)
Inventor
Joseph Chaiken
Robert Dracker
Pamela J Hagrman
Douglas Hagrman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LighTouch Medical Inc
Original Assignee
LighTouch Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LighTouch Medical Inc filed Critical LighTouch Medical Inc
Publication of DE602004032570D1 publication Critical patent/DE602004032570D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
    • G01N21/359—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using near infrared light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/65—Raman scattering
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/645—Specially adapted constructive features of fluorimeters
    • G01N2021/6482—Sample cells, cuvettes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE602004032570T 2003-12-22 2004-12-22 Verfahren zur bestimmung der lebensfähigkeit von zellen Active DE602004032570D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53184803P 2003-12-22 2003-12-22
PCT/US2004/043759 WO2005063119A1 (en) 2003-12-22 2004-12-22 Process and device for determination of cell viability

Publications (1)

Publication Number Publication Date
DE602004032570D1 true DE602004032570D1 (de) 2011-06-16

Family

ID=34738714

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004032570T Active DE602004032570D1 (de) 2003-12-22 2004-12-22 Verfahren zur bestimmung der lebensfähigkeit von zellen

Country Status (6)

Country Link
US (1) US20070177143A1 (de)
EP (1) EP1699351B1 (de)
AT (1) ATE507765T1 (de)
CA (1) CA2549014A1 (de)
DE (1) DE602004032570D1 (de)
WO (1) WO2005063119A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7673290B1 (en) 2003-11-26 2010-03-02 American Megatrends, Inc. Computer implemented configuration of a management module
US7237086B1 (en) 2003-11-26 2007-06-26 American Megatrends, Inc. Configuring a management module through a graphical user interface for use in a computer system
US20050129372A1 (en) * 2003-12-11 2005-06-16 Tieyu Zheng Method and apparatus for manufacturing a transistor-outline (TO) can having a ceramic header
DE102006022877B4 (de) * 2006-05-15 2009-01-29 Sartorius Stedim Biotech Gmbh Verfahren zur Bestimmung der Viabilität von Zellen in Zellkulturen
GB2466442A (en) * 2008-12-18 2010-06-23 Dublin Inst Of Technology A system to analyze a sample on a slide using Raman spectroscopy on an identified area of interest
US8538499B2 (en) * 2009-09-23 2013-09-17 Lightouch Medical, Inc. Process and apparatus for non-invasive, continuous in vivo measurement of hematocrit
US9709500B2 (en) 2012-05-02 2017-07-18 Charles River Laboratories, Inc. Optical method for detecting viable microorganisms in a cell sample
JP6285915B2 (ja) 2012-05-02 2018-02-28 チャールズ リバー ラボラトリーズ， インコーポレイテッド 生死判別染色法
EP2769204B1 (de) 2012-05-02 2016-02-17 Charles River Laboratories, Inc. Zell-auffangsystem und dessen verwendung
CN111655298B (zh) * 2017-11-21 2023-02-03 索尔维克斯有限公司 包含氘代3-o-甲基葡萄糖用于肿瘤疾病磁共振的诊断制剂以及使用所述制剂的诊断方法
CN113740310A (zh) * 2020-05-29 2021-12-03 中国科学院青岛生物能源与过程研究所 一种筛选或评价药物的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3849458A (en) * 1966-01-21 1974-11-19 Incentive Res & Dev Ab Method for deuterating organic compounds
US5167948A (en) * 1987-08-07 1992-12-01 Mallinckrodt Medical, Inc. Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound
US5042488A (en) * 1987-09-29 1991-08-27 The Washington University Methods employing deuterium for obtaining direct, observable deuterium magnetic resonance images in vivo and in situ
US4893627A (en) * 1988-05-26 1990-01-16 The United States Of America As Represented By The United States Department Of Energy Method for nuclear magnetic resonance imaging using deuterum as a contrast agent
US5510894A (en) * 1988-12-22 1996-04-23 Renishaw Plc Spectroscopic apparatus and methods
US5261410A (en) * 1991-02-07 1993-11-16 Alfano Robert R Method for determining if a tissue is a malignant tumor tissue, a benign tumor tissue, or a normal or benign tissue using Raman spectroscopy
US6040906A (en) * 1996-07-11 2000-03-21 Harhay; Gregory P. Resonance raman spectroscopy for identifying and quantitating biomatter, organic, and inorganic analytes
US6149868A (en) * 1997-10-28 2000-11-21 The Penn State Research Foundation Surface enhanced raman scattering from metal nanoparticle-analyte-noble metal substrate sandwiches
US6503478B2 (en) * 1999-01-13 2003-01-07 Lightouch Medical, Inc. Chemically specific imaging of tissue
US20020132371A1 (en) * 1999-09-27 2002-09-19 Kreimer David I. Amplification of analyte detection by substrates having particle structures with receptors

Also Published As

Publication number Publication date
CA2549014A1 (en) 2005-07-14
US20070177143A1 (en) 2007-08-02
EP1699351B1 (de) 2011-05-04
ATE507765T1 (de) 2011-05-15
EP1699351A1 (de) 2006-09-13
WO2005063119A1 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
ATE507765T1 (de) Verfahren zur bestimmung der lebensfähigkeit von zellen
ATE539675T1 (de) System und verfahren zur bestimmung einer analytenkonzentration mit einer hämatokrit- korrektur
ATE278803T1 (de) Verfahren zur überwachung der proteasomeinhibitorarzneimitteleffekte
TW200617380A (en) Concentration determination in a diffusion barrier layer
NO844143L (no) Polymere katalysator transducere og deres bruk i proevesett for analytiske metoder
ATE557101T1 (de) Verfahren und zusammensetzungen zur bestimmung eines transplantationstoleranten phänotyps in einem individuum
WO2007124231A3 (en) A method for measuring and improving organization effectiveness
CY1107859T1 (el) Μεθοδος για διαγνωση πολλαπλης σκληρυνσης
NZ551782A (en) Agents and methods for diagnosing stress
CN104112073B (zh) 一种用于bounce荷载下楼盖振动响应分析的反应谱法
FR2874264B1 (fr) Procede et dispositif de determination de biomasse dans un milieu, notamment d'un milieu contenant des cellules biologiques, et appareil de mesure mettant en oeuvre ce procede
Xiao et al. Ecosystem health and its evolution indicator and method
ATE514951T1 (de) Verfahren zur prüfung eines mehrkanaligen elements zur blutanalyse
DE60310568D1 (de) Verfahren und vorrichtung zur bestimmung der anzahl von lebenden zellen in einer testflüssigkeit
DE112005000698A5 (de) Messvorrichtung und Messverfahren zur Bestimmung von Batteriezellenspannungen
DE502006000385D1 (de) VERFAHREN ZUR ERMITTLUNG VON ABBIEGERATEN IN EINEM STRAßENNETZ
ATE441218T1 (de) Verfahren und anordnung zur detektion von produktwasseransammlung in brennstoffzellen
ATE403877T1 (de) Verfahren zur untersuchung der aktivität von ionenkanälen
ATE464610T1 (de) System, verfahren und computerprogrammprodukt zur bestimmung der wandstärke in einem graphischen modell
DE602006007734D1 (de) Verfahren und system zur echtzeitanalyse von biosensordaten
Brett Are phytoplankton in northern Swedish lakes extremely 13 C depleted?
DE60322743D1 (de) Verfahren zur verwendung teilungsarretierter zellen in screening-assays
CN2603939Y (zh) 用于测定烟碱的离子选择性电极
Lihong et al. Improving the Innovation Ability of Graduate Students by TakingAdvantage of Instrument Sharing Platform
Weisi et al. Assessing and Analyzing the Access Status to Livelihood Assets Among Rural Areas of Marivan County in Order to Provide Sustainable Livelihood for Villagers